TrialThe Lancet. Oncology2020

Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.

Aaron R Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.